Maxfield Capital invests in 3D printing startup Zdravprint
Maxfield Capital, a venture fund operating globally from its offices in Moscow, New York City and Tel Aviv, has invested an undisclosed amount in Zdravprint, a Russian startup that develops medical 3D-printing technology. It is the first time Zdravprint has received venture money, the fund’s Corporate Communications Director Nadir Khabdulin told East-West Digital News.